Organization: Health Canada
Year: 2022
Month: October
Request Number: A-2021-001284
Request Summary: Disclosable Good Manufacturing Practices (GMP) inspection document(s) listing the Inspector’s detailed observations, conditions found, and any follow-up expected by Health Canada for the biologics drug establishment licence GMP foreign regular on-site inspection of the Biocon Biologics India facility Block No. B1, B2, Q13 of Q1 and W20 & Unit S 18, 1st Floor, Block B4; Special Economic Zone; Plot No. 2, 3, 4 & 5, Phase IV, Bommasandra-Jigani Link Road, Bommasandra Post, Bengaluru, Karnataka, India conducted on or around 13 January, 2020. Reference Number 508592.
Disposition: Disclosed in part
Number of pages: 13